A comparison of the intraocular pressure-lowering effect of 0.5% timolol maleate and the docosanoid derivative of a PGF(2alpha) metabolite, 0.12% unoprostone, in subjects with chronic open-angle glaucoma or ocular hypertension
J-P Nordmann, J-F Rouland, Mertz, B P
Published in Current medical research and opinion (01.01.1999)
Published in Current medical research and opinion (01.01.1999)
Get full text
Journal Article
A Comparison of the Intraocular Pressure-lowering Effect of 0.5% Timolol Maleate and the Docosanoid Derivative of a PGF2α Metabolite, 0.12% Unoprostone, in Subjects with Chronic Open-angle Glaucoma or Ocular Hypertension
Nordmann, J.-P., Rouland, J.-F., Mertz, B. P.
Published in Current medical research and opinion (1999)
Published in Current medical research and opinion (1999)
Get full text
Journal Article
Rhegmatogenous retinal detachment in a hypertensive dog
Mertz, B P, Pfister, R, Brueckner, R, Pfannkuch, F
Published in Lens and eye toxicity research (1990)
Get more information
Published in Lens and eye toxicity research (1990)
Journal Article
Recovery from pamidronate (APD): a two-year study in the dog
Grynpas, M D, Kasra, M, Dumitriu, M, Nespeca, R, Very, J M, Mertz, B P
Published in Calcified tissue international (01.10.1994)
Published in Calcified tissue international (01.10.1994)
Get more information
Journal Article
A Comparison of the Intraocular Pressure-lowering Effect of 0.5% Timolol Maleate and the Docosanoid Derivative of a PGF 2α Metabolite, 0.12% Unoprostone, in Subjects with Chronic Open-angle Glaucoma or Ocular Hypertension
Nordmann, J.-P., Rouland, J.-F., Mertz, B. P.
Published in Current medical research and opinion (01.01.1999)
Published in Current medical research and opinion (01.01.1999)
Get full text
Journal Article